CEACAM5 and neoplasm: Mice receiving CEA CAR-T cells overexpressing Bcl-xL had the smaller MC-32 tumor sizes as compared to those receiving the CEA CAR-T cells without overexpressing Bcl-xL or the non-specific T cell control (Figure 7A), correlating with their enhanced survival (n=6; Figure 7B).